Clinical Trial Update: The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing 68Ga-PSMA-11 to enhance diagnosis of primary and metastatic prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostate Cancer Metastatic

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Dana Mathews | Conditions: Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2022-12-20